https://www.PR.com/ Latest news releases from PR.com for Novus Biologicals. Sat, 11 Apr 2026 05:00:54 -0400 © 2026 PR.com 60 en-us https://www.PR.com/images/logo_white.jpg https://www.PR.com/ 68 69 PR.com provides press release distribution, and is a unique directory of businesses, products and services. Find full company profiles. https://www.pr.com/press-release/386649 Sat, 28 Jan 2012 03:00:00 -0500 Novus Biologicals is excited to be a preferred vendor for the University of Washington. Novus’ extensive product line will soon be added to the UW online ordering system, and all UW researchers will now receive 5% off any order. Novus Biologicals is committed to developing and maintaining mutually beneficial relationships with research institutions to improve and shorten the supply chain of research antibodies. If [PR.com] https://www.pr.com/press-release/386649 Novus Biologicals https://www.pr.com/press-release/377428 Sat, 17 Dec 2011 03:00:00 -0500 The Lightning-Link® Rapid Antibody kits allow direct antibody labeling reactions to be set up in seconds and used within just 20 minutes. Novus has recently expanded their Lighting-Link® Rapid kits to include the following DyLight™ dyes. Lightning-Link® Rapid DyLight 350 Lightning-Link® Rapid DyLight 405 Lightning-Link® Rapid DyLight 488 Lightning-Link® Rapid DyLight 550 Lightning-Link® [PR.com] https://www.pr.com/press-release/377428 Novus Biologicals https://www.pr.com/press-release/377191 Fri, 16 Dec 2011 09:26:26 -0500 Novus Biologicals understands the funding constraints and logistical difficulties of starting a new lab. Therefore, Novus is proud to announce a New Lab Program, offering 20% off Novus purchases for your first 3 months. Additionally, Novus will provide a welcome kit full of useful tools for your new lab. Please visit www.novusbio.com/newlab to register a new lab and start receiving the discount immediately. Novus hopes [PR.com] https://www.pr.com/press-release/377191 Novus Biologicals https://www.pr.com/press-release/375617 Thu, 15 Dec 2011 15:39:51 -0500 Novus is proud to announce that select products will now be available through the University of Pennsylvania’s Cell Center Stockroom. Researchers who order through the Cell Center Stockroom will receive a 20% discount off the regular list price and free shipping. The Cell Center Stockroom also supports the Wistar Institute, Monnell, Children’s Hospital of Philadelphia, Presbyterian of Philadelphia, and [PR.com] https://www.pr.com/press-release/375617 Novus Biologicals https://www.pr.com/press-release/368167 Fri, 11 Nov 2011 03:00:00 -0500 Novus Biologicals announced today a new ROBLD3 antibody (catalog number NBP1-71687) for use in research on cell growth regulation. This ROBLD3 antibody was made using SDIX Genomic Antibody TechnologyTM. ROBLD3 is one of three individual proteins (ROBLD3, c11orf59 & MAPKSP1) that form the Ragulator Complex. This complex is a fundamental component of the TORC1 signaling pathway, which begins the signaling cascade for [PR.com] https://www.pr.com/press-release/368167 Novus Biologicals https://www.pr.com/press-release/364779 Sat, 29 Oct 2011 03:00:00 -0400 Novus Biologicals announced today a new CHD7 antibody (catalog number NBP1-77393) for use in research on transcription regulation and CHARGE syndrome. This CHD7 antibody was made using SDIX Genomic Antibody TechnologyTM. CHD7 is an ATP-dependent chromatin remodeler that interacts closely with SOX2 to regulate certain human disease genes. Mutations in CHD7 have been associated with both CHARGE and Kallmann congenital [PR.com] https://www.pr.com/press-release/364779 Novus Biologicals https://www.pr.com/press-release/364149 Thu, 27 Oct 2011 03:00:00 -0400 Novus Biologicals announced today the release of new LDL Receptor (NBP1-78159) and VLDL Receptor (NBP1-78162) antibodies. LDL and VLDL Receptors are similar cell-surface receptor proteins which mediate endocytosis of cholesterol-rich lipoproteins. Both receptors are critical to the lipid and cholesterol metabolism required for proper cellular homeostasis, and defects with these receptors have been implicated in a wide [PR.com] https://www.pr.com/press-release/364149 Novus Biologicals https://www.pr.com/press-release/363782 Wed, 26 Oct 2011 03:00:00 -0400 Novus Biologicals announced today a new Thrombin Receptor antibody (catalog number NBP1-71770) for use in wound healing and cancer research. Thrombin Receptor, also known as Protease activated receptor 1 (PAR1), is a G-protein-coupled receptor that functions in blood clotting. While Thrombin Receptor is known to have important functions in wound healing by inducing human platelet recruitment during thrombosis, it is also [PR.com] https://www.pr.com/press-release/363782 Novus Biologicals https://www.pr.com/press-release/363315 Sun, 23 Oct 2011 03:00:00 -0400 Novus Biologicals announced today a new SDHA Antibody (catalog number NBP1-71688) for use in hypoxia research. This SHDA antibody was made using SDIX Genomic Antibody TechnologyTM. Localized within the mitochondrial inner membrane, Succinate Dehydrogenase A (SDHA) is an important component in the citric acid cycle and respiratory chain. SDHA converts succinate to fumarate while passing electrons along the respiratory [PR.com] https://www.pr.com/press-release/363315 Novus Biologicals https://www.pr.com/press-release/362173 Thu, 20 Oct 2011 03:00:00 -0400 Novus Biologicals announced today a new DICER1 antibody (catalog number NBP1-71691) for use in cell cycle and replication and cancer research. This DICER1 antibody was made using SDIX Genomic Antibody TechnologyTM. DICER1 is a ribonuclease that has been extensively shown to be related to cancer. Small interfering RNAs are generated through DICER, and seem to play important roles in mitosis in normal cells and oncogenesis [PR.com] https://www.pr.com/press-release/362173 Novus Biologicals https://www.pr.com/press-release/361199 Sat, 15 Oct 2011 03:00:00 -0400 Novus is a leading supplier of research antibodies that have been validated for use in model organisms, and they have recently expanded their selection of top quality reagents for Drosophila melanogaster, Caenorhabditis elegans, and Xenopus laevis. These three model organisms are commonly used in lab studies due to their short generational span, relatively simple genome, and ease of care. All Novus antibodies are 100% [PR.com] https://www.pr.com/press-release/361199 Novus Biologicals https://www.pr.com/press-release/359400 Fri, 14 Oct 2011 13:01:49 -0400 Novus Biologicals announced today the winners of two customer contests. First, the third quarter Novus Travel Grant winner is Dr. Toryn Poolman of the University of Manchester's School of Medicine, selected for his excellent review of our Glucocorticoid Receptor Antibody (NB300-610). Dr. Poolman will receive a $500 travel grant covering airfare and conference registration. Submit your review online or contact [PR.com] https://www.pr.com/press-release/359400 Novus Biologicals https://www.pr.com/press-release/360075 Wed, 12 Oct 2011 03:00:00 -0400 Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets. Histone modifications are part of a complicated system of [PR.com] https://www.pr.com/press-release/360075 Novus Biologicals https://www.pr.com/press-release/358836 Thu, 06 Oct 2011 03:00:00 -0400 Novus Biologicals announced today two new Lamin A+C antibodies for use in epigenetic research and for certain cancer research. Lamins and lamin-associated proteins help shape the nucleus and provide a scaffold-type support system for chromosomes and replicating DNA to interact with epigenetic machinery. When mutations to these important proteins occur, serious familial diseases are instigated. The lamin R453W mutation [PR.com] https://www.pr.com/press-release/358836 Novus Biologicals https://www.pr.com/press-release/358396 Wed, 05 Oct 2011 03:00:00 -0400 Novus Biologicals announced today a new LAMP2 antibody (catalog number NBP1-71692) for use as a cell marker in autophagy signaling and cancer research. This LAMP2 antibody was developed using SDIX Genomic Antibody TechnologyTM. LAMP2 is a member of a family of membrane glycoproteins. Specifically, LAMP2 marks selectins with carbohydrate ligands. It is thought that this function plays a role in tumor cell metastasis, as [PR.com] https://www.pr.com/press-release/358396 Novus Biologicals https://www.pr.com/press-release/357296 Fri, 30 Sep 2011 03:00:00 -0400 Novus Biologicals announced today the release of a new group of Epi-PlusTM antibodies for histone modification testing. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets. Histone modifications are part of a complicated system of [PR.com] https://www.pr.com/press-release/357296 Novus Biologicals https://www.pr.com/press-release/356914 Thu, 29 Sep 2011 03:00:00 -0400 Novus Biologicals announced today a new distributor partnership in Argentina with Migliore Laclaustra, S.R.L. Argentina is a biotechnology leader in Latin America, with more than 80 multinational corporations and local companies currently operating nationally. The combination of a highly qualified workforce, developed pharmaceutical industries, large scale embrace of genetically modified crops and increased public and [PR.com] https://www.pr.com/press-release/356914 Novus Biologicals https://www.pr.com/press-release/354876 Wed, 21 Sep 2011 03:00:00 -0400 Today, Novus added a new Histone H3 [dimethyl Lys9/phospho Thr6] antibody to their growing line of EpiPlusTM histone modification antibodies. Over the past several months, Novus has collaborated with 21st Century Biochemicals, a leading manufacturer of custom antibodies and peptides, to generate the most well validated antibodies for modified histones and other epigenetic targets. All Epi-PlusTM antibodies have been [PR.com] https://www.pr.com/press-release/354876 Novus Biologicals https://www.pr.com/press-release/352498 Sun, 11 Sep 2011 03:00:00 -0400 Novus Biologicals announced today a new NODAL antibody (catalog number NBP1-71686) for the study of cancer, angiogenesis and stem cells. This NODAL antibody was made using SDIX Genomic AntibodiesTM (GATTM). This NODAL Antibody (NBP1-71686) serves as an excellent tool for studying stem cell signaling and as a marker for cancer research. NODAL is an important TGF-beta family protein in cellular differentiation. While [PR.com] https://www.pr.com/press-release/352498 Novus Biologicals https://www.pr.com/press-release/346525 Thu, 18 Aug 2011 03:00:00 -0400 Novus’ new Mix-and-Match Pathway Assay Kits allow for the simultaneous detection of activation states of multiple kinases in a signal pathway on a single multiwell platform. Their kits are designed to be much easier and faster than traditional Western blots (2.5 hour protocol), demonstrate a significantly greater dynamic range and sensitivity, operate with much less sample (5-20 micrograms total protein), and are [PR.com] https://www.pr.com/press-release/346525 Novus Biologicals https://www.pr.com/press-release/346278 Wed, 17 Aug 2011 03:00:00 -0400 DUX4 is a transcriptional activator of PITX1, whose expression is epigenetically suppressed in differentiated tissues. DUX4 defects are suspected to cause facioscapulohumeral dystrophy (FSHD), a degenerative skeletal muscle disease and one of the most common muscular dystrophies. In FSHD individuals, the expression of the DUX4 is not completely suppressed in skeletal muscle. Novus’ new DUX4 antibody (Catalog Number [PR.com] https://www.pr.com/press-release/346278 Novus Biologicals https://www.pr.com/press-release/343095 Wed, 03 Aug 2011 03:00:00 -0400 Novus Biologicals announced today a new mouse monoclonal ABCG8 antibody. ABCG8 is an ATP binding cassette family member which acts to exclude non-cholesterol sterol entry to the intestine, to promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into the intestinal lumen. Novus’ new ABCG8 antibody (Catalog Number NBP1-71706) is useful for highly specific Westerm blot, [PR.com] https://www.pr.com/press-release/343095 Novus Biologicals https://www.pr.com/press-release/331984 Mon, 01 Aug 2011 15:50:56 -0400 Novus Biologicals announced today a new VMAT2 antibody (NBP1-69750) for use in neurotransmission research. This VMAT2 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). VMAT2 is a multipass membrane protein responsible for vesicular transport of neurotransmitters by pumping cytosolic monoamines (ie. dopamine, norepinephrine, serotonin, and histamine) into synaptic vesicles. Improper VMAT2 function has [PR.com] https://www.pr.com/press-release/331984 Novus Biologicals https://www.pr.com/press-release/335173 Thu, 30 Jun 2011 03:00:00 -0400 Novus Biologicals, an international supplier of antibodies and antibody-related products to bioscience researchers, is proud to announce the opening of their second international office in Oakville, Ontario, Canada. Novus' other offices include Novus Europe, which services Europe from Cambridge, United Kingdom, and the worldwide headquarters, based in Littleton, Colorado. According to Invest in Canada, the Canadian [PR.com] https://www.pr.com/press-release/335173 Novus Biologicals https://www.pr.com/press-release/316853 Thu, 28 Apr 2011 03:00:00 -0400 Novus Biologicals announced today a new Nkx6.1 antibody (catalog number NBP1-49672) for the study of Pancreatic Stem Cell Markers or Signal Transduction. This Nkx6.1 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Homeobox protein Nkx-6.1 is a bifunctional transcription factor responsible for transcriptional regulation in pancreatic islet beta cells. Specifically, Nkx6.1 binds to specific A/T-rich [PR.com] https://www.pr.com/press-release/316853 Novus Biologicals https://www.pr.com/press-release/316861 Thu, 28 Apr 2011 03:00:00 -0400 Novus Biologicals announced today a new USP22 antibody (catalog number NBP1-49644) for the study of ubiquitin-dependent metabolic pathways. This USP 22 antibody was made using SDIX's Genomic Antibody TechnologyTM (GATTM). Deubiquitinating enzymes (DUBs) comprise a large group of proteases that cleave ubiquitin from proteins to regulate ubiquitin-dependent metabolic pathways. DUB proteins are responsible for ubiquitin [PR.com] https://www.pr.com/press-release/316861 Novus Biologicals https://www.pr.com/press-release/315936 Sat, 23 Apr 2011 03:00:00 -0400 Novus Biologicals is excited to announce a new PINK1 antibody (catalog number NBP1-49678) for the study of mitochondrial markers and neurodegeneration. This PINK 1 antibody was made using SDIX Genomic Antibody TechnologyTM (GATTM). PTEN-induced putative kinase 1 (PINK1) is a mitochondrial serine/threonine-protein kinase, involved in the PTEN tumor suppression pathway. PINK-1 protects cells from stress-induced [PR.com] https://www.pr.com/press-release/315936 Novus Biologicals https://www.pr.com/press-release/311509 Thu, 07 Apr 2011 03:00:00 -0400 AP Endonuclease 1 (APE1), also known as REF-1, is an enzyme primarily responsible for DNA base excision repair. In addition to a DNA repair domain, APE-1 also contains a redox regulation domain to help activate other enzymes involved in the DNA repair pathway. APE 1 is found overexpressed in many human cancers and is required for cancer cell viability, making APE-1 inhibition a potentially important target for cancer [PR.com] https://www.pr.com/press-release/311509 Novus Biologicals https://www.pr.com/press-release/307093 Sun, 20 Mar 2011 03:00:00 -0400 Antibodies against 69 C. elegans chromosomal proteins generated by the modENCODE project are now commercially available through Novus Biologicals, SDIX’s pre-made antibody distributor. The modENCODE project (model organism ENCyclopedia Of DNA Elements) is funded by the NIH to identify all of the DNA sequence-based functional elements in the Caenorhabditis elegans (C. elegans) and Drosophila melanogaster genomes. [PR.com] https://www.pr.com/press-release/307093 Novus Biologicals https://www.pr.com/press-release/307126 Sun, 20 Mar 2011 03:00:00 -0400 Novus Biologicals announced today the release of three new rabbit polyclonal antibodies to important histone demethylase proteins: JMJD2C (Catalog# NBP1-49600), JMJD1A (Catalog# NBP1-49601), and JMJD2A (Catalog# NBP1-49602). All three of these new antibodies cross-react with human and mouse proteins, and are useful for Western blot, immunohistochemistry on paraffin tissues, and fluorescent immunocytochemistry. JMJD2C [PR.com] https://www.pr.com/press-release/307126 Novus Biologicals https://www.pr.com/press-release/303907 Wed, 09 Mar 2011 03:00:00 -0500 Novus Biologicals announces the release of a new rabbit polyclonal TGN46 Antibody for Golgi complex research. [PR.com] https://www.pr.com/press-release/303907 Novus Biologicals https://www.pr.com/press-release/293112 Wed, 26 Jan 2011 03:00:00 -0500 Novus' new Lin28 antibody is useful for immunofluorescence, immunohistochemistry and Western blot. By Western blot, Lin28 antibodies recognize a band at approximately 29kDa. This new Lin28 antibody was validated by Western blot on NTERA-2 cell lysate and 293T cells overexpressing LIN28. [PR.com] https://www.pr.com/press-release/293112 Novus Biologicals https://www.pr.com/press-release/282772 Thu, 09 Dec 2010 03:00:00 -0500 Novus Biologicals just announced a new THAP11 antibody (catalog # NBP1-49463). THAP11 antibodies, also known as Thanatos-associated protein 11 antibodies, are useful for cancer studies and stem cell research. THAP-11 is a regulator of embryonic stem cells and is in the same field as Oct4, Sox2 and Nanog. [PR.com] https://www.pr.com/press-release/282772 Novus Biologicals